Profiling of Germline Mutations in Major Hotspot Codons of TP53 Using PCR-RFLP

Area of Science:

• Molecular Biology
• Cancer Genetics
• Oncology

Background:

• The TP53 tumor suppressor gene is crucial for preventing cancer, with mutations found in approximately 50% of human tumors.
• Most TP53 mutations are missense, frequently occurring at specific 'hotspot codons' within the DNA-binding domain.

Purpose of the Study:

• To analyze the germline mutation status of four TP53 hotspot codons (175, 245, 248, and 72) in cancer patients.
• To evaluate the utility of Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) for detecting these mutations.

Main Methods:

• A case-control study was conducted involving 85 cancer cases and 10 control subjects.
• Germline DNA was analyzed for mutations at TP53 codons 175, 245, 248, and 72 using PCR-RFLP.

Main Results:

• The majority of cancer cases analyzed did not exhibit germline mutations in the four investigated TP53 hotspot codons.
• PCR-RFLP proved to be a simple, cost-effective method for identifying gene mutations.

Conclusions:

• Germline mutations at the studied TP53 hotspot codons are infrequent in the South Indian cancer patient cohort examined.
• PCR-RFLP is a valuable and accessible technique for screening TP53 mutations in clinical settings.